Cover Image
市場調查報告書

心臟植入設備的全球市場分析:各設備 (心律調節器,ICD,CRT,冠狀動脈支架,心臟瓣膜,TAVI瓣膜),各症狀 (心肌缺血,心律不整,急性心肌梗塞)

Cardiac Implant Devices Market Analysis: By Devices (Pacemakers, ICDs, CRTs, Coronary Stents, Heart Valves, TAVI Valves); By Condition (Myocardial Ischemia, Arrhythmias, Acute Myocardial Infarction) - With Forecast (2015-2020)

出版商 IndustryARC 商品編碼 351084
出版日期 內容資訊 英文 180 Pages
訂單完成後即時交付
價格
Back to Top
心臟植入設備的全球市場分析:各設備 (心律調節器,ICD,CRT,冠狀動脈支架,心臟瓣膜,TAVI瓣膜),各症狀 (心肌缺血,心律不整,急性心肌梗塞) Cardiac Implant Devices Market Analysis: By Devices (Pacemakers, ICDs, CRTs, Coronary Stents, Heart Valves, TAVI Valves); By Condition (Myocardial Ischemia, Arrhythmias, Acute Myocardial Infarction) - With Forecast (2015-2020)
出版日期: 2015年07月30日 內容資訊: 英文 180 Pages
簡介

心臟植入設備市場,預計今後數年大幅成長,至2020年達到以年複合成長率12.5%增加的434億美元。技術的進步,心血管疾病的發病率上升,無導線心律調節器等的創新產品的登場等,成為帶動該市場成長的主要原因。

本報告提供全球心臟植入設備市場現狀與今後的市場成長預測,各設備,各症狀趨勢,各地區分析,以及打入市場的主要企業簡介彙整。

第1章 市場概要

第2章 摘要整理

第3章 市場情況

  • 市場佔有率分析
  • 競爭分析
    • 產品基準
    • 專利分析
    • 終端用戶分析
    • 前五名公司財務分析

第4章 市場力量

  • 推動市場的要素
  • 市場抑制力
  • 市場課題
  • 該產業的魅力

第5章 策略性分析

  • 價值鏈分析
  • 機會分析
  • 產品生命週期
  • 價格分析

第6章 各設備

  • 心臟再同步化治療設備
  • 內置心臟去顫器
  • 內置心臟心律調節器
  • 冠狀動脈支架
  • 心臟瓣膜置換/修復設備
  • TAVR

第7章 各症狀

  • 心肌缺血
  • 急性心肌梗塞
  • 心律不整
  • 其他

第8章 各治療

  • 心臟再同步化治療
  • 微創心血管手術
  • 剖腹心血管手術
  • 血管新生
  • 心臟瓣膜修復或置換
  • 其他

第9章 各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 市場熵

  • 新產品上市
  • 合併、收購,聯合,合資企業,聯盟

第11章 企業簡介

第12章 附錄

目錄

Cardiac Implantable devices aim to treat long term heart conditions such as heart failure. These devices are intended to detect any fluctuations in the cardiac system and rectify it automatically or provide support to organs and tissues. Advancement in technology, growing incidences of cardiovascular diseases such as coronary artery diseases (CAD), arrhythmia and launch of new and innovative cardiac products such as leadless pacemakers, subcutaneous defibrillators (S-ICDs) are some of the key drivers for the growth of this market.

The market will show a significant growth in the next few years and is expected to reach $43.4 billion by 2020 at a CAGR of 12.5%. Advancement in technology, growing incidences of cardiovascular diseases such as coronary artery diseases (CAD), atrial fibrillation and aortic aneurysms and launch of new and innovative cardiac products such as leadless pacemakers, subcutaneous defibrillators (S-ICDs) are some of the key drivers for the growth of this market.

In this report different market aspects are explored with particular focus on key market drivers, challenges, constraints and market landscape. The Global market has been thoroughly analyzed and carefully segmented by geographic locations based on major economic and topographical regions.The market for Cardiac implantable devices is classified into several categories based on types of implantable devices, disease conditions and cardiac procedures. They can be utilized in the diagnosis and treatment of various disease conditions such as Myocardial Ischemia, Cardiac Arrest, Arrhythmia, Acute Myocardial Infarction and many others.

Among cardiac implantable devices, coronary stents devices are generating the largest revenue whereas in future TAVR (Transcatheter Aortic Valve Replacement) valves will capture major market segment.

Major market players are profiled along with company overview, financial status, business strategies, product portfolio, recent trends and developments.

The prominent players profiled in this report are:

  • Medtronic Inc.,
  • Boston Scientific Corporation
  • St. Jude Medical Inc.,
  • Abbott Vascular Inc.
  • Edwards Lifesciences Corporation.

The report details current market potential and future market growth in this industry. Overall the report contains the most detailed and in depth segmentation and analysis of the Global Cardiac Implantable Devices Market during the forecast period 2015-2020.

Table of Contents

1. Cardiac Implant Devices Market Overview

2. Executive Summary

3. Cardiac Implant Devices - Market Landscape

  • 3.1. Market Share Analysis
  • 3.2. Comparative Analysis
    • 3.2.1. Product Benchmarking
    • 3.2.2. Patent Analysis
    • 3.2.3. End user profiling
    • 3.2.4. Top 5 Financials Analysis

4. Cardiac Implant Devices - Market Forces

  • 4.1. Market Drivers
  • 4.2. Market Constraints
  • 4.3. Market Challenges
  • 4.4. Attractiveness of the Industry
    • 4.4.1. Power of Suppliers
    • 4.4.2. Power of Customers
    • 4.4.3. Threat of New entrants
    • 4.4.4. Threat of Substitution
    • 4.4.5. Degree of Competition

5. Cardiac Implant Devices Market - Strategic Analysis

  • 5.1. Value Chain Analysis
  • 5.2. Opportunities Analysis
  • 5.3. Product lifecycle
  • 5.4. Pricing Analysis

6. Cardiac Implant Devices Market- By Devices

  • 6.1. Cardiac Resynchronization Therapy Devices (CRT'S)
  • 6.2. Implantable Cardioverter Defibrillators (ICD'S)
  • 6.3. Implantable Cardiac Pacemakers (ICPs)
  • 6.4. Coronary Stents
  • 6.5. Heart Valve Replacement/Repair Devices
  • 6.6. TAVR (Transcatheter Aortic Valve Replacement) Valves

7. Cardiac Implant Devices Market- By Disease Conditions

  • 7.1. Myocardial Ischemia
  • 7.2. Acute Myocardial Infarction
  • 7.3. Arrhythmias
  • 7.4. Others

8. Cardiac Implant Devices Market Classification- By Procedure

  • 8.1. Cardiac Resynchronization Therapy (CRT)
  • 8.2. Minimally Invasive Heart Surgery
  • 8.3. Open heart surgery
  • 8.4. Angioplasty
  • 8.5. Heart Valve Repair or Replacement
  • 8.6. Others

9. Cardiac Implant Devices Market -Geographic Analysis

  • 9.1. North America
    • 9.1.1. USA
    • 9.1.2. Canada
    • 9.1.3. Mexico
    • 9.1.4. Others
  • 9.2. Europe
    • 9.2.1. France
    • 9.2.2. Germany
    • 9.2.3. Italy
    • 9.2.4. Spain
    • 9.2.5. U.K
    • 9.2.6. Others
  • 9.3. APAC
    • 9.3.1. China
    • 9.3.2. India
    • 9.3.3. Japan
    • 9.3.4. Australia
    • 9.3.5. Others
  • 9.4. ROW
    • 9.4.1. South Africa
    • 9.4.2. Russia
    • 9.4.3. Middle East
    • 9.4.4. Others

10. Market Entropy

  • 10.1. New Product Launches
  • 10.2. M&As, Collaborations, JVs and Partnerships

11. Company profiles

  • 11.1. Abbott Vascular Inc.
  • 11.2. Medtronic, Inc.
  • 11.3. Biotronik, Inc.
  • 11.4. Bentley InnoMed GmbH
  • 11.5. Elestim-Cardio
  • 11.6. Cardioelectronica GmbH
  • 11.7. Qualimed Innovative Medizinprodukte Gmbh
  • 11.8. Medico S.p.A
  • 11.9. Lepu Medical Technology
  • 11.10. Boston Scientific Corporation
  • 11.11. St. Jude Medical, Inc.
  • 11.12. Edwards Lifesciences Corporation
  • 11.13. Biosensors International Group, Ltd.
  • 11.14. Japan Lifeline Co., Ltd.
  • 11.15. Sorin S.p.A.
  • 11.16. JenaValve Technology Inc.
  • 11.17. Opto Circuits Limited
  • 11.18. Hexacath
  • 11.19. MicroPort Scientific Corporation.
  • 11.20. Cardionovum GmbH
  • 11.21. Alvimedica
  • 11.22. Amaranth Medical
  • 11.23. Stentys SA

More than 40 Companies are profiled in this Research Report, Complete List available on Request*

"*Financials would be provided on a best efforts basis for private companies"

12. Appendix

  • 12.1. Abbreviations
  • 12.2. Sources
  • 12.3. Research Methodology
  • 12.4. Bibliography
  • 12.5. Compilation of Expert Insights
  • 12.6. Disclaimer
Back to Top